Report
Q&A on the webinar: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance
This Q&A compiles questions asked during the 3 sessions of the webinar on: Pfizer BioNTech COVID-19 Vaccine new formulation: implications on vaccine management, supply chain, and technical assistance.
Authors
- Anahitta Shirzad
-
Maricel Castro
View profile | More articles
Languages
- English
Publication year
2022
Type
Report
Categories
- Supply chain & logistics
Diseases
- COVID-19
Tags
- Vaccine management
